Showing results (141-150 of 170) with videos related to
Sort By:
Pageof 17
Neurology|November 1, 1996
Peptide T in the treatment of painful distal neuropathy associated with AIDS: results of a placebo-controlled trial. The Peptide T Neuropathy Study GroupD M Simpson, D Dorfman, R K Olney, et al.Neurology|May 7, 2008
Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyD M Simpson, J-M Gracies, H K Graham, et al.The International Journal of Biochemistry & Cell Biology|June 1, 1996
Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamicsK M Kelley, Y Oh, S E Gargosky, et al.Neurology|May 14, 2003
Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trialD M Simpson, J C McArthur, R Olney, et al.Southern Medical Journal|April 1, 1994
Outbreaks of syphilis in rural Texas towns, 1991-1992J M Schulte, H A Ramsey, J M Paffel, et al.Neurology|May 1, 1996
Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trialD M Simpson, D N Alexander, C F O'Brien, et al.Annals of Hematology|April 29, 2017
Role of bone marrow biopsy in staging of patients with classical Hodgkin's lymphoma undergoing positron emission tomography/computed tomographyB Puccini, L Nassi, C Minoia, et al.Frontiers in Oncology|March 27, 2026
Correction: Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional networkS Pelliccia, A Di Rocco, G Palumbo, et al.Frontiers in Oncology|March 4, 2026
Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional networkS Pelliccia, A Di Rocco, G Palumbo, et al.Neurology|November 11, 2009
Determinants of survival in progressive multifocal leukoencephalopathyA Marzocchetti, T Tompkins, D B Clifford, et al.Pageof 17